Avantor, Inc. has completed its previously announced acquisition of VWR Corporation to create a global provider of “discovery-to-delivery” solutions, says CEO.
Pharmaceutical Product Development, LLC (PPD), has announced the completed acquisition of Evidera as the two companies commit to making the “seamless offering a reality.”
Aurobindo Pharma has given more details of a planned expansion of its API and antibiotics businesses and has confirmed its intention to rejig its injectables operations.
Following recent acquisitions in the contract packaging industry, Frazier Healthcare says it can compete against insourcing and will lead innovation by focusing on serialization and new technologies.
Onco Therapies Limited (OTL), a division of Aglia, a wholly owned subsidiary of Strides Arcolab Limited, has been given the go ahead from Europe for its Oral Dosage Oncology facility.
Biologics Process Development, a wholly-owned subsidiary of Californian contract research organisation (CRO), Viropro, has announced it is to double the size of its bioprocess and scale-up laboratory.
CMO Avid Bioservices’ year-on-year revenues increased by 440 per cent in the second quarter, leading to the company planning expansions in Asia-Pacific, biosimilars and analytical services.
The availability of preclinical capacity and uncertainty created by mergers and healthcare reform have led to pharma exerting pricing pressure on Charles River, decreasing its sales by 13.1 per cent, and it expects the situation to worsen in Q4.
Contract research organisation PPD has boosted its compound partnering programme with the purchase of dermatology specialist Magen BioSciences, and divested its presclinical research subsidiary Pedmont Research Centre.
Japan’s Shionogi is paying $1.4bn (€959m) for US drugmaker Sciele Pharma as part of a plan to strengthen its sales position in the country’s $286bn a year drug market.
LabTechnologist.com presents its periodic round up of recent
industry news with the latest developments in the fight
to buy Biosite as well as news from Agilent, Dionex, and
Millipore.
Nanogen and Fisher Scientific have announced an expansion to their
relationship to include a research and development collaboration in
molecular diagnostics. The collaboration agreement complements
Fisher's equity investment...
US-based contract research organisation The Smithers Group,
announced the acquisiton of UK company Rapra Technology in a deal
that seals the fate of Rapra, which was forced into Administration
last month.
Drug delivery specialists, Inyx has announced the acquisition of
Celltech Manufacturing Services from biopharmaceutical company UCB
for €27.5 million (€22.3 million). The acquisition adds to Inyx's
recently established operating...
Respironics, a US-based company specialising in sleep and
ventilation products, is to make a $44.6 million (€37.3m) cash
offer for Profile Therapeutics of the UK.
German drug major Bayer has entered into a collaboration with
Artemis Pharmaceuticals focusing on the development of
genetically-engineered mice that are designed to have human-like
biology. The ArteMice will be used in Bayer's...
SC Biosciences is to be the exclusive distributor of sensitive
tools for drug discovery with the announcement this week that it
will distribute in vivo imaging technology in Japan for US company
Xenogen corporation.
